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1. Introduction 
Nuclear magnetic resonance (NMR) has become an important technique for determining the 
three-dimensional (3D) structure of biological macromolecules. Since 1985, it has been used to 
determine the structures of approximately 8,000 proteins, 1,000 DNA/RNA complexes and 
180 protein/nucleic acid complexes (http://www.pdb.org/pdb/ statistics/holdings.do). At 
first, NMR was limited to relatively small and soluble proteins or protein domains. The 
study of large proteins was hindered by the presence of overlapping large peaks in the 
NMR spectra. This has been in part alleviated by the introduction of isotope (2H, 15N, 13C) 
labeling and multidimensional (3D, 4D) experiments (Sattler et al., 1999). By using these 
techniques, it is now possible to study proteins up to 40 kDa. For instance, the 3D solution 
structure of the maltodextrin-binding protein (41kDa) has been recently solved using NMR 
(Madl et al., 2009; Figure 1A). Comprehensive NMR studies of integral membrane proteins 
in solution have long been impaired by substantial problems of sample preparation, 
including the inability to produce sufficient quantities of isotopically labelled protein as well 
as the difficulties associated with the limited thermal stability, sample heterogeneity and 
short lifetimes of such proteins. However, NMR allows investigation of the very 
conformational mobility that to a large extent interferes with the process of crystallization of 
membrane proteins. Thus, by focusing on proteins with a sufficient expression yield and 
screening sample and detergent conditions in a microtiter-plate format, it has been possible 
to determine 71 structures of integral membrane proteins corresponding to 49 unique 
proteins (http://www.drorlist.com/ nmr/MPNMR.html). The first NMR structure 
determination of a detergent-solubilized seven-helix transmembrane (7TM) protein, the 
phototaxis receptor sensory rhodopsin II (pSRII) from Natronomonas pharaonis, was recently 
reported to illustrate that NMR can provide structures of large membrane proteins (Gautier 
et al., 2010; Figure 1B). The challenge is now to apply similar techniques to the study of 
other 7TM proteins, including G-protein coupled receptors (GPCRs) that represent the most 
important class of targets for current therapeutic agents. These proteins can only be 
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expressed in small quantities and are of limited stability, particularly in their unbound state. 
Samples must be conformationally and chemically homogeneous and stable at high 
concentrations. Despite these problems, there are encouraging indications suggesting that, 
in the near future, heterologous expression systems will provide labelled GPCRs in 
sufficient quantities for NMR analysis to characterize the details of the interactions between 
GPCRs and their ligands. 
 
                                                 A                                                     B 
Fig. 1. Ribbon representation of the solution NMR structures of (A) the maltodextrin-
binding protein (PDB ID 2KLF; Madl et al., 2009) and (B) the phototaxis receptor sensory 
rhodopsin II (pSRII) from Natronomonas pharaonis (PDB ID 2KSY; Gautier et al., 2010). 
Most NMR studies of biological macromolecules have been carried out in solution. Since 
about 10 years ago, developments in NMR technology, sample preparation, pulse-sequence 
methodology and structure calculation protocols have allowed the structure determination 
of several proteins by solid-state NMR spectroscopy. Thus, 17 structures corresponding to 
11 unique proteins have been solved using oriented samples of protein/lipids mixture 
(http://www.drorlist.com/ nmr/SPNMR.html). In particular, the M2 protein, a small 
membrane protein that enables hydrogen ions to enter the influenza A viral particle, was 
characterized by NMR to better understand its 3D structure and its interaction with drugs 
used against flu (Hu et al., 2010; Sharma et al., 2010; Figure 2A). Solid-state NMR was also 
used to solve 18 structures corresponding to 5 proteins forming fibrils (Van Melckebeke et 
al., 2010; Figure 2B) and 8 proteins yielding microcrystalline samples (Jehle et al., 2010; 
Figure 2C). Like liquid-state NMR, solid-state NMR is based on local structure information. 
As a consequence, large amounts of data on several differently labelled samples are 
typically required to obtain sufficient long-range information. However, NMR is 
particularly useful to study fibrils and microcrystals because these preparations are highly 
ordered on a local scale and consequently show narrow resonance lines. In recent years, 
considerable progress has been made in using solid-state NMR spectroscopy to determine 
atomic-resolution structures of amyloid fibrils associated with serious disorders such as 
Alzheimer disease, Parkinson disease, prion diseases and type 2 diabetes mellitus (for 
review: Tycko, 2011). Although the architecture of fibrils is considered to be a continuous 
stack of ǃ-sheet ladders termed a cross-ǃ structure, there may be significant variations in the 
supramolecular organization of the peptides within the fibrils. NMR provides detailed 
insight on the structural organization of these fibrils, highlighting their assembly process 
and inspiring the design of fibril-binding compounds and inhibitors.  
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             A                                     B                                                          C 
Fig. 2. Ribbon representation of the solid-state NMR structures of (A) the M2 
transmembrane peptide of the influenza A virus in DMPC lipid bilayers (PDB ID 2KQT; 
Cady et al., 2010), (B) the HET-s(218-289) prion in its amyloid form (PDB ID 2KJ2; Van 
Melckebeke et al., 2010) and (C) the -crystallin domain in B-crystallin oligomers (PDB ID 
2KLR; Jehle et al., 2010). 
NMR can be used to study a large panel of molecular complexes, including those 
characterized by a low affinity binding interaction. At the present time, NMR has been used 
to solve about 1,500 3D structures of protein complexes. The majority of these structural 
studies have been performed on complexes characterized by submicromolar affinities. In 
cases of weak binding, characterized by a millimolar to micromolar affinity, it is possible to 
map and characterize details of the interface. The simplest and most popular approach is the 
so-called "chemical shift mapping" technique wherein changes in backbone chemical shifts 
of one molecule are monitored during titration with another molecule by recording a series 
of heteronuclear single-quantum correlation (HSQC) spectra (Figure 3). Upon addition of a 
ligand, chemical shift, line width and intensity changes of specific HSQC peaks indicate that 
the corresponding residues experience a modification of their chemical environment. This 
modification is due to the complex formation, and may result either from the proximity 
between the observed residue and the ligand or from binding-induced conformational 
changes in the first molecule close to the observed residue. The exact effects of the complex 
formation on the HSQC spectrum depend on the relative values of the NMR time scale and 
the exchange rate of the complex. The NMR time scale refers to the chemical shift scale: 
differences in chemical shifts between species in exchange. If this difference is larger than 
the exchange rate, then the exchange is classified as SLOW. If this difference is equal to the 
exchange rate, then the exchange is INTERMEDIATE. If this difference is smaller than the 
exchange rate, the exchange is FAST. Protein-protein interactions with Kd < 1ǍM (tight 
binding) are generally in slow exchange. In this case, two NMR signals are seen for the free 
and bound forms. During the titration, the free form signal gradually disappears and the 
bound form signal appears. Protein-protein interactions with Kd > 1mM (weak binding) are 
generally in fast exchange. In such cases, only one averaged signal is seen with a chemical 
shift fractionally weighted according to the populations and chemical shifts of the free and 
bound forms. Protein-protein interactions with a Kd between 1 ǍM and 1 mM are generally 
in intermediate exchange. This gives rise to broadened signals from both the free and bound 
forms. During addition of a ligand, identification of the NMR peak changes and mapping of 
these changes onto the protein structure provides information on the binding interface and 
the conformational changes of the protein due to the interaction (Figure 3). Analysis of these 
data opens up great opportunities for understanding the dynamics of interaction networks 
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(Mackereth et al., 2011). Which molecules are in competition for binding to the studied 
protein? Which molecules bind simultaneously?  Is a conformational change necessary for 
the complex formation? Is this conformation change involved in the regulation of other 
interactions? How multiple domain proteins exploit their flexibility in order to recognize 
their targets?  
 
           A                                                      B                                                          C 
Fig. 3. Mapping of binding sites by NMR. (A) In the presence of free and ligand-bound 
proteins, the NMR signal varies as a function of the exchange rate. Its chemical shifts and 
linewidths evolve from a FAST exchange to a SLOW exchange condition. When the 
exchange is FAST, only one averaged chemical shift is observed. When it is SLOW, the 
chemical shifts corresponding to the free and bound forms are observed. (B) The chemical 
shift changes measured during the titration of a labelled protein with its binding partner are 
displayed in the case of FAST exchange (upper panel) and SLOW exchange (lower panel). 
(C) Residues whose NMR chemical shifts and/or linewidths change during the titration 
with ligands A and B are colored in red and orange, respectively, on the surface 
representation of the 3D structure of the labelled protein. This “chemical shift mapping” 
study shows that the labelled protein recognizes its two ligands by different surfaces. 
NMR allows for direct observations of NMR-active nuclei (1H, 15N, 13C, 31P) within any 
NMR-inactive environment and can therefore be employed to investigate the structures of 
appropriately labelled biomolecules either in cell extracts or inside live cells. It has been 
used to structurally characterize biomolecules in the presence of cell extracts, in order to 
investigate post-translational modifications, conformational changes and binding events at 
the residue level within macromolecules in conditions mimicking the cellular environment 
(Liotakis et al., 2010). To accomplish this, NMR-active labelled recombinant proteins are 
injected into cell extracts and their chemical shift evolution is followed in the extracts after 
addition of specific enzyme co-factors or binding partners. These experiments are 
particularly powerful at describing the molecular binding events regulated by post-
translational modifications. Furthermore, NMR has been applied to the observation of 
protein-protein interactions and the determination of protein structures in E. coli. The so-
called STINT-NMR approach entails sequentially expressing two (or more) proteins within a 
single bacterial cell in a time-controlled manner and monitoring the protein interactions 
using in-cell NMR spectroscopy (Burz et al., 2006). NMR has also been used to follow the 
behavior of intrinsically disordered proteins in the crowded environment of bacterial cells 
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(Dedmon et al., 2002). The 3D structure of the putative heavy-metal binding protein 
TTHA1718 from Thermus thermophilus HB8 was solved from data acquired on living E. coli 
samples (Sakakibara et al., 2009). In eukaryotic cells, the first in-cell NMR studies were 
performed by injecting proteins into Xenopus laevis oocytes (Selenko et al., 2006).  Cell-
penetrating peptides have also been used to deliver labelled proteins that can be observed in 
living cells (Inomata et al., 2009). However, the low sensitivity of the method and the short 
lifetime of the samples have so far prevented the acquisition of structural data in most of 
these eukaryotic systems. Development of ultra-fast methods for multidimensional 
experiments has already contributed to the first successes of in-cell NMR and should be 
further exploited to follow biological events.  
Solid-state and liquid-state NMR techniques are now essential tools for understanding 
biological processes from a mechanistic point of view at the atomic level. They can describe 
critical steps of a disease mechanism, highlight the mechanism of action of a particular drug 
and inspire the design of binding compounds and complex assembly inhibitors. We will 
now focus on the use of NMR for the elucidation of the molecular mechanisms of specific 
genetic diseases caused by either missense mutations or amino acid deletions/insertions in 
several proteins located at the nuclear envelope.  
2. NMR and genetic diseases involving the nuclear envelope 
We have used NMR to study the molecular mechanisms of genetic diseases caused by 
mutations in genes encoding inner nuclear membrane proteins (see for examples Krimm et 
al., 2002 and Caputo et al., 2006). These proteins play critical roles in nuclear structure and 
positioning (Figure 4). They also influence genome spatial and temporal organization and 
genome functional properties. Because of their many biological functions, the pathological 
mechanisms resulting from mutations are complex and not well understood (Dauer & 
Worman, 2009). A wide range of diseases affecting different organs system have been linked 
to mutations in the LMNA gene, encoding the A-type nuclear lamins, which are 
intermediate filament proteins mainly located at the inner nuclear membrane of 
differentiated somatic cells. These diseases include dilated cardiomyopathy with variable 
muscular dystrophy, Dunnigan-type familial partial lipodystrophy, a Charcot-Marie-Tooth 
type 2 disease, mandibuloacral dysplasia and Hutchinson-Gilford progeria syndrome. 
Adult-onset autosomal dominant leukodystrophy is caused by duplication of the gene 
encoding lamin B1, which is an intermediate filament protein located at the inner nuclear 
membrane of all nucleated somatic mammalian cells. In addition, several diseases are linked 
to mutations in genes encoding integral proteins of the inner nuclear membrane that are 
associated with nuclear lamins, such as emerin, LBR and MAN1. Structural studies of the 
proteins involved in these so-called “laminopathies” or “nuclear envelopathies” have 
provided mechanistic clues about the functions of the nuclear envelope and insights into the 
disease pathogenesis. 
Some mutations causing laminopathies are frameshifts or premature termination codons 
resulting in truncated protein. In these cases, the protein is generally rapidly degraded and 
its function is lost. NMR can however be used to structurally characterize the native protein, 
thus providing molecular details on its lost function (Caputo et al., 2006). Others mutations 
generate amino acid substitutions that can destabilize the protein leading to its premature 
degradation, interfere with its degradation pathway or modify its interaction with other 
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proteins or nucleic acids. In these cases, NMR can provide information on the structural 
consequences of the mutation (Krimm et al., 2002). Does the mutation affect a hydrophobic 
residue in the core of the protein and thus destabilize its 3D structure? Does it affect a 
residue at the surface of the protein that is critical for a specific interaction with a biological 
partner? Structural studies utilizing NMR, by identifying the structural consequences of the 
missense mutations, can point out specific disease mechanisms. Such information could be 
used to develop therapies targeted to the defects. 
 
Fig. 4. Architecture of the nuclear envelope (reproduced with permission from Chi et al., 
2009). The nuclear lamina, comprising the A- and B-type lamins, interacts with several 
proteins anchored at the inner nuclear membrane such as LBR, emerin, MAN1 and SUN1/2. 
SUN1/2 proteins also interact with outer nuclear membrane proteins that in turn bind to 
microtubules and actin. This network of protein-protein interactions is essential for cell 
structural organization.  
We have used NMR to study A-type lamins, showing how different types of mutations that 
cause different diseases affect protein structure, hence providing clues about pathogenesis. 
We have also used NMR to study LEM domain proteins, which mediate interactions 
between the inner nuclear membrane and DNA and are involved in bone and muscle 
diseases. We have further analysed in detail MAN1, a LEM domain protein that regulates a 
key signal transduction pathway and whose heterozygous loss of function causes sclerosing 
bone dysplasias.  
Many proteins associated with cellular control and signalling mechanisms such as A-type 
lamins and LEM domain proteins are modular in structure in that they contain both well-
folded domains and poorly-structured regions (Wright & Dyson, 2009). The presence of 
poorly-folded regions facilitates protein accessibility to modifying enzymes and interaction 
with a wide variety of targets. However, this also hinders protein structural 
characterization, as the poorly-structured regions can adopt a large number of 
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conformations and fold into different structures on binding to different target proteins. The 
pathological consequences of mutations located in the poorly-folded regions would then not 
be observed on the 3D structure of the mutated protein but instead linked to modifications 
of its binding properties. To tackle the structural description of these proteins, we chose to 
(1) solve the 3D solution structures of their globular domains and (2) characterize the 
relative positioning of domains within sub-regions. This “divide-and-conquer” approach is 
based on the combination of NMR spectroscopy and small-angle X-ray scattering (SAXS) 
and is a powerful method to characterize the structural ensemble of partially disordered 
proteins (Madl et al., 2011). From the description of the three-dimensional structures of sub-
regions of A-type lamins and LEM domain proteins, we then (1) determined the impact of 
disease-linked mutations on the structure and stability of the proteins, (2) mapped 
interaction surfaces of proteins with their biological partners, (3) positioned the mutations 
relatively to these functionally important surfaces and (4) characterized the 3D structure of 
complexes involving these proteins. 
3. How do mutations in A-type lamins cause different diseases? 
3.1 Architecture of the lamin intermediate filaments 
Nuclear lamins are classified as either A-type or B-type according to homology in sequence, 
biochemical properties and localization during the cell cycle. In humans, the LMNB1 and 
LMNB2 genes encode lamin B1 and B2, respectively, which are expressed in most or all 
nucleated somatic cells.  The LMNA gene encodes the A-type lamins and the major isoforms, 
lamin A and lamin C, are expressed in most differentiated somatic cells. Lamins A and C are 
produced by alternative RNA splicing. They share a common region from amino acids 1-566 
and differ at their C-terminus, from amino acids 567-664 for prelamin A, the lamin A 
precursor that is processed to lamin A, and from amino acids 567-572 for lamin C.  
Like all intermediate filament proteins, lamins are fibrous in nature and share a tripartite 
structural organization. A non-ǂ-helical N-terminal region (head) and a C-terminal region 
(tail) flank a central ǂ-helical coiled-coil domain (rod). Lamins differ from the cytoplasmic 
intermediate filament proteins in that they have an extended rod domain (42 amino acid 
longer), that they have a nuclear localization signal (NLS) between their rod and tail regions 
and that they display a typical tertiary structure in this tail region (Herrmann et al., 2009; 
Figure 5). In contrast to most cytoplasmic intermediate filament proteins, lamins also 
contain sites for phosphorylation by mitotic kinases and most contain carboxy-terminal 
CAAX motifs that signal posttranslational modification by farnesylation. The lamin -helical 
central rod domain is divided into three coiled regions (termed 1A, 1B and 2), which 
mediate lamin assembly into filaments. In vitro experiments have revealed that elementary 
lamin dimers first assemble through longitudinal N–C interactions and then these 
assemblies associate through lateral interactions to form intermediate filaments.  
X-ray crystallography has been used to determine the atomic structure of various fragments 
of the lamin intermediate filament rod domain (Herrmann et al., 2009).  In particular, it has 
been used to solve the crystal structure of a human lamin A fragment comprising residues 
305 – 387, which corresponds to the second half of coil2 (PDB ID 1X8Y; Strelkov et al., 2004). 
This structure revealed a left-handed parallel coiled-coil extending to the predicted end of 
the rod domain (Figure 5). Essentially the same fragment of lamin B1 has also been resolved 
and a similar structure was observed (PDB ID 3MOV). Interestingly, the crystal structure of 
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another human lamin A fragment (residues 328–398), which is largely overlapping with 
fragment 305–387 but harbours a short segment of the tail domain, was also solved. 
Unexpectedly, there is no parallel coiled-coil form within the crystal. Instead, the ǂ-helices 
are arranged such that two antiparallel coiled-coil interfaces are formed (PDB ID 2XV5). The 
most significant interface has a right-handed geometry, which results from a characteristic 
15-residue repeat pattern that overlays the canonical heptad repeat pattern (Figure 5). 
Analysis of these different modes of coil association gives some clues about the mechanisms 
of lamin polymerization in cells (Kapinos et al., 2011). Several polymerization mechanisms 
have been proposed that could co-exist and be modulated by specific chaperone-type 
molecules as well as post-translational modifications. 
 
Fig. 5. Architecture of lamins, adapted with permission from Kapinos et al., 2011. (A) 
General structural organization of lamin monomers. Two A-type lamin coil 2 fragments 
were studied at atomic resolution (PDB IDs 1X8Y and 2XV5). Their X-ray structures are 
displayed in the cartoon, in which the sequence of amino acids 328-382, common to both 
fragments, is colored in gray and the remaining residues colored blue (N-terminus) or red 
(C-terminus). (B) Two models of lamin filament structural organization proposed from the 
analysis of the rod fragment X-ray structures. The C-terminal rod sections of two dimers 
labelled 1 and 3 are colored blue and the N-terminal rod section of dimer 2 is colored green. 
Broken lines represent coiled-coil interfaces that have been observed in crystal structures 
and dotted lines indicate other theoretically possible coiled coil interactions.  
We have solved the 3D solution structure of the C-terminal globular domain of A-type 
lamins, which participates to the recognition of various lamin binding proteins (PDB ID 
1IVT; Krimm et al., 2002). Determination of this structure was made from experimental 
measured values of short inter-proton distances (<6 Å) obtained by 1H, 15N and 13C NMR on 
a 13C and 15N labelled sample of the domain. Figure 6A shows the well-dispersed 1H-15N 
HSQC spectrum of the C-terminal globular domain of A-type lamins. The labeling was 
Coil 2 assembly with coil 1
Nter 
Nter
Nter 
Nter 
Model 1
 
 
 
Model 2 
A 
B
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essential to assign the inter-proton distances obtained by 1H NMR to specific proton pairs. 
Molecular modeling calculations were used to calculate a family of 3D structures, all very 
close one to the other, compatible with the distances measured by NMR (Figure 6B). These 
structures, which reflect the structure of the domain in solution, have an immunoglobulin 
fold between residues 430 and 545. Crystal structures of this C-terminal domain of A-type 
lamins have also been solved and show similar structural organization (Dhe-Paganon et al., 
2002; PDB IDs 1IFR and 1UFG).   
 
Fig. 6. Structural characterization of the globular domain found in the tail region of lamins. 
(A) 1H-15N HSQC spectrum of the domain from human A-type lamin. This spectrum was 
acquired on a 40 M protein sample in 250 l phosphate buffer pH 7.4 over 1 hour using a 
700 MHz Bruker spectrometer. Each residue of the domain is revealed by a peak whose 
position depends on the residue chemical environment. Well-folded domains exhibit well-
dispersed peaks, as shown for the lamin tail domain. (B) Cartoon representation of the 3D 
structure of the fragment of amino acids 428-549 from human A-type lamin, as calculated 
from NMR experimental data. 
3.2 Post-translational modification of A-type lamins 
Lamins undergo post-translational modifications that alter their localization, assembly 
and binding properties. Prelamin A is converted into lamin A by four enzymatic post-
translational processing steps: farnesylation of a cysteine in a CAAX motif at the carboxyl 
terminus of the protein, endoproteolytic cleavage of the last three amino acids of the 
protein, carboxyl methylation of the newly exposed farnesylcysteine and subsequent 
endoproteolytic release of the last 15 amino acids, including the farnesylcysteine methyl 
ester. B-type lamins also contain a CAAX motif and undergo the first three of these 
enzymatic reactions but not the last. A-type and B-type lamins are also phosphorylated by 
cyclin dependent kinases, which regulate nuclear lamina assembly and disassembly 
during mitosis. Other phosphorylation, acetylation and sumoylation events have also 
been reported whose physiological importance is largely unknown. According to the 
PhosphoSite database, more than 60 phosphorylation sites are present in human A-type 
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lamins. Most of these are located in unstructured regions of the proteins (Figure 7). These 
phosphoresidues could be important for lamin functions by regulating interactions with 
other nuclear proteins. 
 
Fig. 7. Phosphorylation sites in human A-type lamins that have been reported in the 
PhosphoSite database (http://www.phosphosite.org/). 
Post-translational modifications can be followed by NMR, either by adding the appropriate 
enzyme to the labelled protein sample or by diluting the labelled protein into cell extracts 
and adding the appropriate co-factor (Liotakis et al., JACS 2010). Series of NMR spectra are 
then recorded to follow the protein chemical shift evolution with time. Residues whose 
chemical shifts are modified because of the presence of enzymes in the sample are 
identified. These residues are either the targets of the enzyme or are close to the modified 
residues. NMR is particularly efficient in dissecting the modification kinetics of protein 
regions rich in inter-dependant modification sites. 
3.3 Localization and structural impact of disease-linked missense mutations identified 
in A-type lamins 
Several different diseases are caused by mutations in the LMNA gene encoding lamin A and 
C (Worman et al., 2010). More than 1,500 mutations have been identified within this gene. 
Amino acid substitutions in various regions of A-type lamins cause striated muscle diseases, 
partial lipodystrophy or progeroid disorders but in most cases a correlation between the 
localization of the mutation and the disease phenotype is not readily apparent. We searched 
for a correlation between the localization of the mutated residue in the lamin 3D structure 
and the disease phenotype. We focused on the lamin tail globular domain, because amino 
acid substitutions in this region cause either striated muscle diseases, lipodystrophy or 
progeroid disorders. Analysis of the position of the mutated residues in the NMR structure 
of the immunoglobulin-like domain and experimental measurement of the impact of several 
selected mutations on this structure were carried out (Krimm et al., 2002). We observed that 
most dominantly inherited mutations causing diseases of striated muscle affect residues of 
the hydrophobic core of the immunoglobulin-like domain (Figure 8A). These mutations 
probably destabilize the 3D structure of this domain, leading to an overall loss of protein 
function. Such destabilization has been experimentally verified for the Arg453Trp mutant. 
In contrast, dominantly inherited mutations causing Dunnigan-type familial partial 
lipodystrophy, a disease affecting adipose tissues, affect residues located at the surface of 
the immunoglobulin-like domain and cluster at a specific positively charged site (Figure 8B). 
This site is conserved in A-type and B-type lamins. This suggests that mutations causing 
www.intechopen.com
NMR Spectroscopy as a Tool to Provide Mechanistic  
Clues About Protein Function and Disease Pathogenesis 
 
153 
adipose tissue diseases do not destabilize the domain structure but may hinder the 
interaction of A-type lamin with a binding partner that plays a critical role in adipose tissue. 
Recessive mutations in the immunoglobulin-like domain of A-type lamins causing 
progeroid disorders also affect residues located at the surface of this domain and cluster at a 
specific site (Figure 8C; Verstraeten et al., 2006). This hot spot is distinct from the surface 
affected in partial lipodystrophy and is conserved in A-type lamins. It may correspond to 
another protein binding site specific to A-type lamins, with mutations causing progeroid 
disorders hindering this putative interaction. Experiments to identify the proteins 
interacting with A-type lamins at the different identified hot spots are now underway.  
 
                      A                                                     B                                                 C 
Fig. 8. Localization of the residues identified as mutated in laminopathies in the 3D structure 
of the tail globular domain of A-type lamins (PDB ID 1IVT; Krimm et al., 2002; Verstraeten 
et al., 2006). In (A), residues mutated in striated muscle diseases are displayed in blue sticks. 
In (B), residues mutated in adipose tissue diseases are displayed in red sticks. In (C), 
residues mutated in progeria-like diseases are displayed in green sticks.  
3.4 Perspectives: NMR study of how lamin post-translational modifications affect 
protein structure and interactions 
Several studies have shown that the lamin tail globular domain and the flexible lamin 
regions are involved in binding to other proteins. We know that flexible regions of lamins 
are highly modified in cells (Figure 7). This suggests that post-translational modifications 
could be involved in regulating lamin recognition. In fact, post-translational modification of 
partners has already been shown to be involved in regulating lamin binding. For example, 
lamin A is involved in the sequestration of c-Fos, a member of the dimeric activator protein 
1 (AP-1) transcription factor family that regulates different cellular pathways including cell 
proliferation, death survival differentiation and oncogenic transformation. Phosphorylation 
of c-Fos by ERK1/2 protein kinase reduces lamin A/c-Fos interaction, thus activating AP1 
complexes (Gonzales et al., 2008).  
In-cell NMR is a useful way to analyse these regulation pathways involving post-
translational modifications of lamins or lamin partners. Using NMR chemical shift mapping 
as presented in part 1, modified residues can be identified onto the lamin tail or onto its 
binding partners. Next, interaction between modified or unmodified lamins and their 
binding partners, and conversely between lamins and modified or unmodified partners, can 
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be tested. Our strategy is to produce recombinant lamins and partners and inject them into 
human cell extracts with or without addition of cofactors that are essential for post-
translational-modifications. Figure 9 shows our first 1H-15N HSQC spectra of the tail region of 
lamin C incubated into 293T cell extracts during 1 to 24 hours. This experiment shows that it is 
possible to follow the fate of a partially unfolded protein in cell extracts during one day. 
 
Fig. 9. Following modification and binding events involving the lamin C tail in 293T cell 
extracts: feasibility experiments. 1H-15N HSQC spectra were recorded on a Bruker 700 MHz 
spectrometer after 1 hour (red) and 24 hours (blue) of incubation of a 50 M sample of 
labelled protein in 250 l of cell extracts at 5mg/ml. The protein is stable in these conditions. 
Co-factors should then be added in order to allow modification of the labelled protein. 
4. How do mutations in LEM domain proteins affect interactions between the 
nuclear envelope and chromatin? 
4.1 Architecture of LEM domain proteins 
LAP2 isoform ǃ (LAP2 ǃ), emerin and MAN1 are human nuclear proteins that share a 
highly conserved structural motif called the LEM domain (Lin et al., 2000). The LEM domain 
contains approximately 50 amino acids. It is located at the N-terminus of these proteins and 
is often separated from the rest of the protein by predicted unstructured regions (Figure 10). 
Both MAN1 and emerin possess one copy of the LEM domain in their N-terminal 
nucleoplasmic region whereas LAP2 contains a LEM-like domain and a LEM domain 
connected by a predicted unstructured linker.  
The 3D solution structures of emerin and LAP2  LEM domains and LAP2  LEM-like 
domain have been solved using NMR (Wolff et al., 2001; Laguri et al., 2001; Cai et al., 2001). 
These LEM and LEM-like domains share a similar 3D structure, mainly composed of a short 
N-terminal helix and two large ǂ-helices interacting through a set of conserved amino acids 
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residues (Figure 10). NMR characterization of the fragment from amino acids 1-168 of LAP2 
 containing both the LEM-like and LEM domains has shown that the two domains are 
structurally independent, non-interacting domains connected by an approximately 60-
residue flexible linker (Cai et al., 2001).  
 
                                                 A                                                                                B 
Fig. 10. Schematic organization of nuclear envelope proteins containing a LEM domain. 
(A) Three human inner nuclear membrane proteins are displayed: LAP2 ǃ, MAN1 and 
emerin. Dark blue boxes represent LEM domains, the light blue box represents a LEM-like 
domain, green rectangles represent transmembrane segments. (B) Ribbon representation 
of the average solution structure of the LEM domain of LAP2  (PDB ID 1H9F; Laguri et 
al., 2001).    
4.2 LEM domains recognize the DNA binding BAF protein 
Barrier-to-autointegration factor (BAF) is a highly conserved metazoan protein, which 
functions in nuclear assembly, chromatin organization and gene transcription. BAF dimers 
bind to double-stranded DNA non-specifically and thereby bridge DNA molecules to form a 
large, discrete nucleoprotein complex. BAF is able to interact simultaneously with both 
LAP2 and DNA in vitro (Shumaker et al., 2001). This suggested that LEM proteins and BAF 
mediate chromatin attachment to the nuclear envelope during nuclear assembly or 
interphase, or both. 
The interaction between the fragment containing amino acids 1-168 of LAP2  and the BAF–
DNA complex was characterized by NMR (Cai et al., 2001). It was proposed on the basis of 
chemical shift mapping experiments that the LEM-like domain recognizes DNA (Figure 
11A) while the LEM domain recognizes the DNA binding protein BAF (Figure 11B). 
However, when the whole BAF-DNA complex was added to the labelled LAP2  fragment, 
only the peaks corresponding to the LEM domain shifted, indicating that only the LEM 
domain interacts with the BAF–DNA nucleoprotein complex (Figure 11C). 
Subsequently, the solution structure of the BAF-emerin LEM domain complex was solved 
on the basis of NMR data (Cai et al., 2007). This structure revealed that one BAF dimer 
interacts with one emerin LEM domain (Figure 12A). The stoechiometry of the complex 
prevents association between one molecule of BAF dimer and multiple LEM domain 
proteins.  Moreover, the interaction surface between BAF and emerin does not overlap with 
the two symmetry related DNA binding sites on the BAF dimer (Figure 12B). Thus, BAF can 
simultaneously interact with emerin and DNA.  
Nter                    Cter 
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Fig. 11. Mapping the LAP2  residues involved in BAF–DNA nucleoprotein recognition 
(reproduced with permission from Cai et al., 2001). (A) Comparison of the 1H-15N HSQC 
spectra of LAP2  region containing amino acids 1-168 in the absence (red) and presence 
of 1.5 equivalents (blue) of a duplex DNA dodecamer. Only cross-peaks of the LEM-like 
domain shift upon DNA binding. (B) Comparison of 1H-15N HSQC spectra of LAP2  
region 1-168 in the absence (red) and presence (blue) of one equivalent of BAF. Only the 
cross-peaks in the LEM domain change significantly upon binding to BAF. (C) 
Comparison of the 1H-15N HSQC spectra of LAP2  region containing amino acids 1-168 
in the absence (red) and presence (blue) of the BAF–DNA nucleoprotein complex. Only 
the peaks originating from the LEM domain disappear upon binding the BAF–DNA 
nucleoprotein complex.  
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                            A                                                                            B 
Fig. 12. Ribbon representation of (A) the solution structure of the BAF2 dimer (orange) bound 
to the emerin LEM domain (red) (PDB ID 2ODG; Cai et al., 2007) and (B) the X-ray structure of 
the BAF2 dimer (orange) bound to DNA (blue) (PDB ID 2BZF; Bradley et al., 2005).  
4.3 Localization and structural impact of disease-linked mutations identified in emerin 
and BAF 
X-linked Emery-Dreyfus muscular dystrophy (EDMD) is characterized by early contractures 
of the spine, Achilles tendon and elbows, muscle wasting in a humerperoneal distribution 
and dilated cardiomyopathy with conduction system abnormalities (Muchir & Worman, 
2007). It is caused by mutations in the EMD gene encoding emerin (Bione et al., 1994), an 
integral protein of the inner nuclear membrane. At present, 130 mutations homogeneously 
distributed along the EMD gene have been reported (Brown et al., 2011). Approximately 
90% of these mutations result in the complete absence of protein as characterized by 
immunohistochemical staining. The few mutations allowing modified emerin protein 
expression yield protein that is expressed in reduced amounts and is frequently 
mislocalized. The majority of patients with residual emerin expression display clinical 
phenotypes indistinguishable from their null counterparts. However, it is difficult to argue 
that there is no discernable genotype-phenotype correlation, as clinical data collection on 
EDMD patients is often incomplete. Moreover, the relationship between emerin absence or 
decreased expression and muscle abnormalities is poorly understood. As emerin has been 
hypothesized to regulate muscle specific gene expression and nuclear architecture, some 
have suggested that absence or reduced levels affect cellular susceptibility to mechanical 
stress, cellular proliferation and differentiation (Fidziańska & Hausmanowa-Petrusewicz, 
2003; Frock el al., 2006).  
Recently, a mutation (A12T) in the BANF1 gene encoding BAF has been shown to induce a 
progeroid syndrome that shares physiopathological characteristics with Hutchinson-Gilford 
progeria syndrome (HGPS) (Puente et al., 2011). HPGS has received considerable attention 
because of its striking premature aging phenotype, including alopecia, diminished 
subcutaneous fat, premature atherosclerosis, and skeletal abnormalities. The vast majority of 
HGPS cases are associated with a de novo nucleotide substitution at position 1824 (C->T) in 
the LMNA gene encoding A-type lamins (Eriksson et al., 2003; De Sandre-Giovannoli et al., 
2003). This mutation does not affect the coded amino acid (and is thus generally referred to 
as G608G), but partially activates a cryptic splice donor site in exon 11 of LMNA, leading to 
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the production of a prelamin A mRNA that contains an internal deletion of 150 base pairs. 
This transcript is then translated into a protein known as progerin, which lacks 50 amino 
acids near the C terminus. The new progeroid syndrome caused by a mutation in BAF 
differs from HGPS by the fact that affected patients have not cardiovascular deficiencies and 
live longer. A 3D model of BAF shows that the mutated residue is located on the surface of 
the protein (Figure 13). Nevertheless, the A12T mutation is not predicted to affect BAF 
dimerization or binding to either DNA or emerin, raising the possibility that this amino acid 
substitution could impair the interaction with other proteins, its subcellular localization or 
its stability. Examination of the effect of the BAF A12T mutation in the fibroblasts of affected 
patients showed a reduction in protein levels, indicating that this mutation affects the 
stability of BAF.  Surprisingly, the decrease in BAF appears to be linked to a delocalization 
of emerin in the endoplasmic reticulum and abnormalities in the nuclear lamina. In HeLa 
cells that overexpressed a phosphomimetic BAF missense mutant S4E, but not S4A, emerin 
also mislocalized from the nuclear envelope (Bengtsson & Wilson, 2005). Furthermore, 
phosphorylation of serine 4 inhibited BAF binding to emerin and lamin A in blot overlay 
assays. These results suggest that the N-terminal region of BAF is normally involved in 
emerin localization at the nuclear envelope and that the A12T mutation could destabilize a 
lamin-emerin-BAF complex. Structural data on this complex are lacking so further structural 
analysis of the consequences of the BAF A12T mutation is not currently possible. 
 
Fig. 13. 3D model of a BAF dimer (orange and light orange in the figure) in complex with 
emerin (red) and DNA (cyan) built from the PDB files 2ODG and 2BZF. The position of the 
T12 residue in mutant BAF is indicated in pink sticks (Puente et al., 2011). 
5. How do mutations in the inner nuclear envelope MAN1 deregulate TGF 
signaling? 
5.1 Architecture of MAN1, a LEM domain protein with an R-Smad binding C-terminal 
region 
The LEMD3 gene encodes MAN1, an integral protein of the inner nuclear membrane (Lin et 
al., 2000). MAN1 consists of 911 amino acids and exhibits two transmembrane domains 
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(Figure 14A). Its N-terminal and the C-terminal regions are located on the nucleoplasmic 
side of the membrane. The N-terminal nucleoplasmic region of MAN1 (amino acids 1-471) 
contains an N-terminal LEM (Figure 14B). This domain is essential for emerin, lamin and 
BAF binding (Liu et al., 2003; Mansharamani & Wilson, 2005). We have used 1H, 15N and 13C 
NMR and SAXS to study the structural organization of the C-terminal nucleoplasmic region 
of MAN1 (Caputo et al., 2006; Kondé et al., 2010).  This region is composed of a globular 
winged helix (WH) domain (Figure 14C), a linker region, a globular U2AF Homology Motif 
(UHM) domain (Figure 14D) and a C-terminal unstructured region. The WH domain 
presents a fold found in several transcription factors and it recognizes DNA (Caputo et al., 
2006). The UHM domain is essential for MAN1 binding to Smad2 and Smad3 that are 
transcriptional regulators of the TGF pathway (Lin et al., 2005; Pan et al., 2005). The C-
terminal region also recognizes other transcription regulators as the death-promoting 
transcriptional repressor Btf and the transcriptional repressor germ-cell-less GCL 
(Mansharamani & Wilson, 2005). 
 
Fig. 14. Structural organization of the MAN1 protein. (A) Domain composition of MAN1 
(the two transmembrane regions are colored in green) and localization of the mutations 
causing bone genetics diseases (Hellemans et al., 2004). (B) Model of the LEM domain of 
MAN1, built by homology on the basis of the LAP2  LEM domain structure (PDB ID 1H9F; 
Laguri et al., 2001). (C) NMR structure of the WH domain (PDB ID 1CH0; Caputo et al., 
2006). (D) Model calculated for the UHM domain on the basis of the secondary structure 
information deduced from the NMR chemical shift analysis and the 3D structure of the 
UHM domain of U2AF65 (PDB ID 1O0P; Kondé et al., 2010). 
To understand the mechanisms of regulation of the TGFǃ pathway by MAN1, we 
characterized the molecular determinants of its interaction with Smad2 and Smad3. We 
showed that the first WH domain is not essential for Smad2 binding. However, the linker 
region as well as the UHM domain and the C-terminus are all involved in Smad2 binding. 
NMR and SAXS data were used to reconstitute the fluctuating 3D structure of the Smad2 
binding region of MAN1 (Kondé et al., 2010).  
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Fig. 15. Structural organization of the Smad2 binding motif of MAN1 (adapted with 
permission from Kondé et al., 2010). (A) NMR 1H-15N HSQC spectra of the wild-type 
(yellow) and mutated (W765A-Q766A, green) Smad2 binding motif of MAN1, representing 
the NMR finger print of the fold adopted by these protein fragments. Each NMR peak is 
assigned to the backbone NH bond of a specific amino acid in MAN1 sequence, and its 
position in the spectrum reflects its chemical environment in the protein domain. (B) NMR 
chemical shift mapping of the UHM region interacting with the linker. On the black ribbon 
representation of the MAN1 UHM model, residues whose 1H-15N HSQC peak is largely 
shifted and could not be assigned due to the mutations W765A and Q766A are colored in 
red, residues whose HSQC peak is shifted by more than 1.5 times the root mean square 
deviation of the chemical shift difference distribution but could still be assigned are 
coloured in orange, and residues whose HSQC peak could not be assigned in the 
MAN1LuhmWQ spectra are colored in cyan. The surface of the opposite face of the UHM 
domain is showed as an additional view. (C) Comparison of the SAXS data recorded on the 
wild-type (blue) and mutated (W765A-Q766A, red) Smad2 binding motif of MAN1. The upper 
view displays the superposition of the logarithm of the SAXS intensities as a function of the 
amplitude of the diffusion vector q = 4*π*sin(θ)/ǌ. The lower view corresponds to the 
superposition of the Kratky plots: the diffusion vector amplitude multiplied by the gyration 
radius is plotted on the abscissa and the square of the abscissa multiplied by the SAXS 
intensity divided by the intensity at 0 is plotted on the ordinate. This representation reveals the 
type of structure: compact, partially folded or unfolded. (D) Model of the Smad2 binding 
domain of MAN1 consistent with the NMR and SAXS data. The backbone is represented as a 
ribbon; the side chains of W765 and Q766, in the linker, and of several residues lining the 
hydrophobic cavity of the UHM domain are displayed as sticks. (E) Fluorescence polarization 
curves of the labelled wild-type (left) and mutated (W765A-Q766A, right) Smad2 binding 
fragment of MAN1 as a function of the concentration in Smad2. 
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We mutated the highly conserved W765 and Q766 of the linker region and observed the 
consequences of these mutations on the NMR 1H-15N spectrum of the Smad2 binding region 
(Figure 15A). Residues with NMR signals modified by the mutations were mapped onto the 
UHM domain (Figure 15B). They all clustered on one face of the domain and delineated a 
hydrophobic pocket in which the tryptophane residue binds. We performed SAXS 
experiments on samples of wild type and mutated Smad2 binding region. SAXS provides 
accurate information on folding and conformation in solution for both rigid and flexible 
macromolecules and the indirect Fourier transform of the SAXS intensity gives access to the 
real space electron pair distance distribution of molecules in solution. Figure 15C (upper panel) 
shows that the SAXS curves of the wild type and mutated protein fragments are similar, 
reflecting their common global fold. Calculation of the electron pair distance distributions 
using GNOM gave access to the radius of gyration Rg, the maximal distance and the I0 value 
that cannot be measured experimentally and is proportional to the mass. From these values, a 
Kratky representation was displayed (Figure 15C, lower panel) that highlighted structural 
differences between wild-type and mutated proteins: the maximum of the curve 
corresponding to (SRg)2 I/Io is shifted towards higher SRg values, reflecting the more 
elongated/less structured state of the mutant. Moreover, the wild type protein shows a 
gyration radius between 20 and 21 Å and a maximal distance between 68 and 72 Å, whereas 
the mutant shows a gyration radius between 23.3 and 24 Å and a maximal distance is close to 
90 Å. This result validates our previous NMR based analysis that strongly suggests a role of 
W765 and Q766 in anchoring the linker onto the UHM domain. In contrast, the C-terminus of 
the Smad2 binding region of MAN1 is partially unfolded. From these observations, the 
positions of the linker and C-terminus regions relatively to the UHM domain were calculated, 
yielding to a model of the whole Smad2 binding region of MAN1 (Figure 15D). The functional 
importance of the positioning of the linker region onto the UHM domain was shown using 
fluorescence binding experiments: mutations of the W765 and Q766 residues into alanine 
yielded a 15-fold decrease of the affinity of MAN1 for Smad2 (Figure 15E). 
5.2 Mechanism of bone diseases caused by the absence of the C-terminal region of 
MAN1 
Heterozygous loss-of-function mutations in LEMD3 encoding MAN1 cause the sclerosing 
bone dysplasias osteopoikilosis, Buschke-Ollendorff syndrome and non-sporadic 
melorheostosis (Hellemans et al., 2004). Several arguments suggest that the bone diseases 
result from enhanced TGF-ß signalling in cells.  
First, all the disease-causing mutations including nonsense or frameshift mutations induce 
loss of the C-terminal nucleoplasmic fragment of MAN1, which is essential for Smad2 
recognition (Figure 14A). Second, the TGF-ǃ pathway is enhanced in cells from patients 
(Hellemans et al., 2004). Loss of the MAN1-Smad2 interaction may lead to the release of 
activated Smad2 and Smad3, thus causing an increase of Smad2 dependant transcription 
(Lin et al., 2005; Pan et al., 2005). It has been proposed that MAN1-Smad2 interaction not 
only sequestrates Smad2 and Smad3 at the inner nuclear envelope, but also favours their 
nuclear export (Pan et al., 2005; Figure 16). However, the mechanism by which the 
nucleoplasmic MAN1 C-terminal region would stimulate this nuclear export remains 
unclear. MAN1 could simply act as a “nuclear envelope sink” for activated nuclear Smad 
proteins, sequestering them at the inner nuclear membrane (Figure 16-1) and competitively 
inhibiting interactions with other nuclear factors involved in gene regulation (Figure 16-2). 
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Another hypothesis, also proposed for the MAN1 paralog NET25 (Huber et al., 2009), is that 
MAN1 functions as a scaffold protein recruiting Smad2, Smad3 and kinases/phosphatases 
to the inner nuclear membrane. Phosphorylation of Smad linker residues by kinases such as 
MAPKs or dephosphorylation of Smad C-terminal residues by phosphatases would then 
lead to enhanced nuclear export (Figure 16-3).  
 
Fig. 16. The role of MAN1 in the TGF-ǃ signaling pathway. The TGF-ß family of cytokines 
comprises key regulators of metazoan embryonic development and adult tissue homeostasis. 
In the canonical pathway, ligands of both the TGF-ß and the bone morphogenetic protein 
members of this family bind to heteromeric serine/threonine kinase receptor complexes, 
which in turn phosphorylate R-Smad transcription factors at their C-terminal tails. Upon 
phosphorylation, the R-Smads trimerize. This trimerization allows the R-Smads to interact 
with the common mediator Smad4. Then, these complexes translocate to the nucleus where 
they interact with various transcription factors, bind to DNA, and regulate transcription of 
targeted genes. MAN1 is able to influence the TGF-ß signalling by directly interacting with 
Smad2 and Smad3 (Hellemans et al., 2004; Lin et al., 2005). This leads to an inhibition of the 
TGF-ß signalling pathway (Pan et al., 2005). We suggest several putative mechanisms for the 
TGF-ǃ pathway regulation by MAN1. (1) MAN1 could sequestrate the activated complexes R-
Smads-Smad4 at the inner nuclear membrane, thus decreasing R-Smads accessibility to its 
targeted genes. (2) MAN1 could also compete with transcription factors for R-Smads binding 
resulting in a decrease of the transcriptional activity of R-Smads proteins. (3) MAN1 could 
recruit enzymes that modify R-Smads resulting in dissociation of active R-Smads-Smad4 
complexes and nuclear export of R-Smads. 
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We used protein binding assays and isothermal calorimetry experiments to map the Smad2 
binding site onto the MAN1 structure (Kondé et al., 2010). These experiments suggested that 
MAN1 recognizes Smad2 through a motif similar to the Smad Interaction Motif found in 
transcription factors. MAN1 could thus compete with transcription factors for Smad2 and 
Smad3 binding. Further experiments are needed to characterize the fate of Smads after 
MAN1 binding.  
6. Conclusion 
1H, 15N and 13C NMR spectroscopy provide structural data which, when combined to SAXS 
data, allow the determination of the 3D structures of partially unfolded proteins. It is now 
possible to describe not only the structural consequences of disease-linked mutations 
located in well-folded domains but also their impact on the structural organisation of 
modular proteins (Mackereth et al., 2011). Such results provide mechanistic clues about how 
partially folded proteins use conformational switches in order to regulate their functions 
and highlight the connection between conformational variability, interaction and disease 
pathogenesis. Regulation of the function of modular proteins is also based on protein 
modifications. Recent studies propose that NMR characterization of a 15N labelled protein in 
cell extracts can be a unique tool to examine changes in protein structure and interaction 
properties upon modification (Liokatis et al., 2010).  
Characterization of interaction properties of disease-linked proteins is critical to 
understanding pathogenic mechanisms and may identify other genes to be screened in 
similar pathologies. NMR is a powerful tool to map low affinity (mM to M) interaction 
surfaces and determine high affinity (nM to pM) complex structures, and must be used in 
conjunction with other methods such as isothermal calorimetry or fluorescence to deduce 
the nature, affinity and stochiometry of the interaction. Analysis of these parameters aims at 
highlighting the competitive or synergic role of the studied interaction within the large 
cellular protein-protein interaction network, and at identifying how disease-linked 
mutations perturb this functional network. 
All theses different approaches highlight NMR spectroscopy as a technique adapted to the 
description of the consequences of disease-linked mutations in partially unfolded and multi-
partner proteins, as those associated with cellular control and signalling mechanisms. It has 
become an essential tool for understanding such biological processes from a mechanistic 
point of view at the atomic level. It can describe critical steps of disease mechanisms, 
highlight the mechanism of action of a particular drug and inspire the design of binding 
compounds and complex assembly inhibitors. NMR could be used in the future to develop 
therapies targeted to the defects. 
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